Visakha Pharma Innovation And Incubation Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-01-2025
- Paid Up Capital ₹ 0.50 M
as on 06-01-2025
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
About Visakha Pharma Innovation And Incubation
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Popuri Krishna, Pakanati Reddy, and Udayampalayam Senthilkumar serve as directors at the Company.
- CIN/LLPIN
U73100AP2022PLC122816
- Company No.
122816
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Sep 2022
- Date of AGM
07 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Visakha Pharma Innovation And Incubation?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Popuri Krishna  | Director | 20-Sep-2022 | Current |
| Pakanati Reddy | Director | 05-Feb-2024 | Current |
| Udayampalayam Senthilkumar | Director | 30-Oct-2023 | Current |
Financial Performance of Visakha Pharma Innovation And Incubation.
Enhance accessibility to Visakha Pharma Innovation And Incubation's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Visakha Pharma Innovation And Incubation?
Unlock access to Visakha Pharma Innovation And Incubation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ramky - Midc Agro Processing Park LimitedActive 16 years 11 monthsPakanati Reddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Visakha Pharma Innovation And Incubation?
Visakha Pharma Innovation And Incubation has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Visakha Pharma Innovation And Incubation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Visakha Pharma Innovation And Incubation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
